Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-06-01 · accession 0001209191-23-033551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale | $25.67 | -2,500 | 106.8K | -2% | -$64.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | S | D | 2,500 | $25.67 | 106,840 | D | — | — | (F2) Includes 926 shares of common stock acquired by the reporting person on May 31, 2023 pursuant to an employee stock purchase program. |